NM_005219.5(DIAPH1):c.2015G>A (p.Gly672Asp) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Dec 12, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003788156.2

Allele description [Variation Report for NM_005219.5(DIAPH1):c.2015G>A (p.Gly672Asp)]

NM_005219.5(DIAPH1):c.2015G>A (p.Gly672Asp)

Gene:

DIAPH1:diaphanous related formin 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

5q31.3

Genomic location:

Preferred name:

NM_005219.5(DIAPH1):c.2015G>A (p.Gly672Asp)

HGVS:

NC_000005.10:g.141573835C>T
NG_011594.2:g.50221G>A
NM_001079812.3:c.1988G>A
NM_001314007.2:c.2015G>A
NM_005219.5:c.2015G>AMANE SELECT
NP_001073280.1:p.Gly663Asp
NP_001300936.1:p.Gly672Asp
NP_005210.3:p.Gly672Asp
LRG_1117t1:c.1988G>A
LRG_1117t2:c.2015G>A
LRG_1117:g.50221G>A
LRG_1117p1:p.Gly663Asp
LRG_1117p2:p.Gly672Asp
NC_000005.9:g.140953402C>T

Protein change:

G663D

Molecular consequence:

NM_001079812.3:c.1988G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001314007.2:c.2015G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_005219.5:c.2015G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Autosomal dominant nonsyndromic hearing loss 1
Synonyms:: KONIGSMARK SYNDROME; Deafness, autosomal dominant 1; DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA
Identifiers:: MONDO: MONDO:0007424; MedGen: C1852282; Orphanet: 90635; OMIM: 124900

Name:: Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome
Synonyms:: Seizures, cortical blindness, and microcephaly syndrome
Identifiers:: MONDO: MONDO:0014714; MedGen: C5567650; OMIM: 616632

Recent activity

Clear Turn Off Turn On

ubiquitin specific peptidase 11 [Mus musculus]
ubiquitin specific peptidase 11 [Mus musculus]
gi|31981834|ref|NP_663603.2|

Protein
Ubiquitin specific peptidase 11 [Mus musculus]
Ubiquitin specific peptidase 11 [Mus musculus]
gi|13529494|gb|AAH05470.1|

Protein
S.cerevisiae chromosome XV reading frame ORF YOR269w
S.cerevisiae chromosome XV reading frame ORF YOR269w
gi|1420603|emb|Z75177.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004603545	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Dec 12, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004603545

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Dec 12, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004603545.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 672 of the DIAPH1 protein (p.Gly672Asp). This variant has not been reported in the literature in individuals affected with DIAPH1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine